Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25320147 | 0.67 | EGLN1 (0.31) | EGLN1 | |
| SCHEMBL25427716 | 0.61 | — | — | |
| SCHEMBL2344195 | 0.56 | CAD (0.43) | — | |
| SCHEMBL630497 | 0.56 | CAD (0.43) | — | |
| SCHEMBL3625069 | 0.56 | CAD (0.43) | — | |
| SCHEMBL28321908 | 0.55 | — | — | |
| SCHEMBL1355425 | 0.55 | OAT (0.60) | OAT | |
| SCHEMBL9845677 | 0.55 | OAT (0.37) | OAT | |
| SCHEMBL10777579 | 0.55 | OAT (0.37) | OAT | |
| SCHEMBL31289649 | 0.55 | DPP4 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022117893-A2 | COMBINATION THERAPY FOR PATIENTS HAVING ACUTE AND/OR PERSISTENT DYSPNEA | S-FORM PHARMA (BE) | 2022-06-09 | — | — | WO | claimed |
| WO-2022117893-A2 | COMBINATION THERAPY FOR PATIENTS HAVING ACUTE AND/OR PERSISTENT DYSPNEA | S-FORM PHARMA (BE) | 2022-06-09 | — | — | WO | disclosed |
| US-20210145964-A1 | STROMA-TARGETING TREATMENT FOR PATIENTS WITH ELEVATED ADAM12 LEVELS | ACADEMISCH MEDISCH CENTRUM (NL) | 2021-05-20 | — | — | US | disclosed |